| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |